Scientific article
English

Expectations and strategies regarding islet transplantation: metabolic data from the GRAGIL 2 trial

Published in

Transplantation, vol. 84, no. 1, p. 89-96

Publication date

2007

Abstract

Whether islet transplantation should be aimed at restoring insulin independence or providing adequate metabolic control is still debated. The GRAGIL2 trial was designed as a phase 1-2 study where primary outcome was the rate of insulin independence, and secondary outcome was the success rate defined by a composite score based upon basal C-peptide, HbA1c, hypoglycemic events, and exogenous insulin needs.

Keywords

  • Adult
  • Blood Glucose/metabolism
  • Clinical Trials as Topic
  • Diabetes Mellitus, Type 1/metabolism/surgery
  • Female
  • Follow-Up Studies
  • Humans
  • Hypoglycemia/physiopathology
  • Immunosuppressive Agents/adverse effects/therapeutic use
  • Insulin/secretion
  • Islets of Langerhans Transplantation/adverse effects/methods
  • Male
  • Middle Aged
  • Multicenter Studies as Topic
  • Optic Nerve Diseases/chemically induced
  • Severity of Illness Index
  • Treatment Outcome

Citation (ISO format)

BADET, Lionel et al. Expectations and strategies regarding islet transplantation: metabolic data from the GRAGIL 2 trial. In: Transplantation, 2007, vol. 84, n° 1, p. 89–96. doi: 10.1097/01.tp.0000268511.64428.d8

Main files (1)

Article (Published version)

Identifiers

Journal ISSN

0041-1337
835views
0downloads

Technical informations

Creation

26/02/2014 12:37:00

First validation

26/02/2014 12:37:00

Update

14/03/2023 20:59:33

Status update

14/03/2023 20:59:33

Last indexation

30/10/2024 16:22:44
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated